SCHEMBL31723151

SCHEMBL31723151

O=C(O)c1c(-c2cccc(F)c2)oc2cc(Cl)ccc2c1=O

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TTR P02766 4/20 0.49
GABRP O00591 1/20 0.48
GABRD O14764 1/20 0.48
GABRA1 P14867 1/20 0.48
GABRB1 P18505 1/20 0.48
GABRG2 P18507 1/20 0.48
GABRB3 P28472 1/20 0.48
GABRA5 P31644 1/20 0.48
GABRA3 P34903 1/20 0.48
GABRA2 P47869 1/20 0.48
GABRB2 P47870 1/20 0.48
GABRA4 P48169 1/20 0.48
GABRE P78334 1/20 0.48
GABRA6 Q16445 1/20 0.48
GABRG1 Q8N1C3 1/20 0.48
GABRG3 Q99928 1/20 0.48
GABRQ Q9UN88 1/20 0.48
MEN1 O00255 3/20 0.47
KMT2A Q03164 3/20 0.47
ALDH1A1 P00352 2/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22284777 1.00 TTR (0.49) TTRGABRPGABRDGABRA1GABRB1
SCHEMBL31723124 0.92 ALDH1A1 (0.57) TTRGABRPGABRDGABRA1GABRB1
SCHEMBL20918175 0.92 ALDH1A1 (0.57) TTRGABRPGABRDGABRA1GABRB1
SCHEMBL31723140 0.86 MAPT (0.59) TTRMEN1KMT2AALDH1A1KDM4E
SCHEMBL20919306 0.86 MAPT (0.59) TTRMEN1KMT2AALDH1A1KDM4E
SCHEMBL31723167 0.86 MAPT (0.62) MEN1KMT2AALDH1A1KDM4EMAPT
SCHEMBL28427603 0.86 MAPT (0.62) MEN1KMT2AALDH1A1KDM4EMAPT
SCHEMBL20918216 0.85 KMT2A (0.57) TTRGABRPGABRDGABRA1GABRB1
SCHEMBL31723120 0.85 KMT2A (0.57) TTRGABRPGABRDGABRA1GABRB1
SCHEMBL20918138 0.83 ALDH1A1 (0.56) MEN1KMT2AALDH1A1KDM4EMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3699174-B1 COMPOSITION FOR PREVENTING OR TREATING TNF-RELATED DISEASES, CONTAINING DERIVATIVE AS ACTIVE INGREDIENT, AND METHOD FOR INHIBITING TNF ACTIVITY BY USING SAME ILAB (KR) 2025-11-12 EP claimed